Wikidata

(Q45760907)

English

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).

scientific article published on 7 November 2012

In more languages

Statements

title
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23136231
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23136231%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45760907&oldid=1406556504"